ID 607 -
Wielonienasycone kwasy tłuszczowe omega-3
PL: Wielonienasycone kwasy tłuszczowe omega-3
EN: Omega-3 fatty acids
Pdf: n-3 polyunsaturated fatty acids
1. Charakterystyka żywności / składnika
The food constituent that is the subject of the health claims is n-3 polyunsaturated fatty acids (PUFAs).
n-3 PUFAs are polyunsaturated fatty acids with one of the double bonds located at the third carbon atom from the methyl end. The quantitatively most important n-3 PUFAs in the diet are 18:3 (alpha-linolenic acid, ALA), 20:5 (eicosapentaenoic acid, EPA), 22:5 (docosapentaenoic acid, DPA), and 22:6 (docosahexaenoic acid, DHA) (EFSA Panel on Dietetic Products Nutrition and Allergies (NDA), 2010). EPA, DPA and DHA are classified as long-chain PUFAs (LC-PUFAs).
n-3 PUFAs are recognised nutrients and are measurable in foods by established methods; they are well absorbed when consumed in the form of triglycerides. This evaluation applies to n-3 PUFAs from all sources with appropriate bioavailability in the specified amounts.
The Panel considers that the food constituent, n-3 PUFAs, which is the subject of the health claims, is sufficiently characterised.
2.3. Utrzymanie prawidłowego stanu kości (ID 607)
The claimed effect is “fonctionnement osseux”. The Panel assumes that the target population is the general population.
In the context of the proposed wordings, the Panel assumes that the claimed effect refers to the maintenance of normal bone through the promotion of calcium absorption.
The Panel considers that maintenance of normal bone is a beneficial physiological effect.
3.2. Utrzymanie prawidłowego stanu kości (ID 607)
The references provided for the scientific substantiation of the claim were narrative reviews which addressed the potential role of n-3 PUFAs and other nutrients on bone metabolism, and which did not provide original data for the scientific substantiation of the claim. The Panel considers that no conclusions can be drawn from these references for the scientific substantiation of the claim.
The Panel concludes that a cause and effect relationship has not been established between the consumption of n-3 PUFAs and maintenance of normal bone.
Warunki i możliwe ograniczenia stosowania oświadczenia
340mg/j
